Screener
Staar Surgical STAA Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Staar Surgical in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Staar Surgical’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000718937-26-000023
| Line item | April 3, 2026 | January 2, 2026 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $131,864 | $153,150 |
| Investments available for sale (amortized cost basis of $32,028 and $34,385 at April 3, 2026 and January 2, 2026, respectively) | 32,025 | 34,386 |
| Accounts receivable trade, net of allowance for credit losses of $799 and $83 at April 3, 2026 and January 2, 2026, respectively | 81,172 | 50,064 |
| Inventories, net | 49,784 | 55,496 |
| Prepayments, deposits and other current assets | 17,553 | 18,449 |
| Total current assets | 312,398 | 311,545 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Staar Surgical's cash & equivalents?
- Staar Surgical (STAA) reported cash & equivalents of $131.86M in Q1 2026.
- How has Staar Surgical's cash & equivalents changed year-over-year?
- Staar Surgical's cash & equivalents decreased by 23.8% year-over-year, from $173.11M to $131.86M.
- What is the long-term trend for Staar Surgical's cash & equivalents?
- Over 5 years (2020 to 2025), Staar Surgical's cash & equivalents has grown at a 0.1% compound annual growth rate (CAGR), from $152.45M to $153.15M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Staar Surgical's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude